LLY Analyst Ratings & Price Targets
Eli Lilly and Company
Consensus rating
The consensus across 30 analysts covering Eli Lilly and Company is Buy.
Price targets
The spread between the lowest and highest target is the number worth looking at. A range of $930.00 to $1,600.00 on the same company, at the same time, on the same public information, is a fair measure of how much of a price target is judgement rather than arithmetic.
Recent rating changes
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 10, 2026 | HSBC | Maintained | Reduce | $940.00(from $850.00) |
| Aug 7, 2026 | Truist Securities | Maintained | Buy | $1,376.00(from $1,370.00) |
| Aug 6, 2026 | Wells Fargo | Maintained | Overweight | $1,330.00(from $1,280.00) |
| Aug 6, 2026 | Cantor Fitzgerald | Maintained | Overweight | $1,410.00(from $1,350.00) |
| Jul 15, 2026 | Citigroup | Maintained | Buy | $1,600.00(from $1,500.00) |
| Jul 14, 2026 | Bernstein | Maintained | Outperform | $1,385.00(from $1,300.00) |
| Jul 13, 2026 | UBS | Maintained | Buy | $1,425.00(from $1,250.00) |
| Jul 13, 2026 | Guggenheim | Maintained | Buy | $1,273.00(from $1,235.00) |
| Jul 10, 2026 | B of A Securities | Maintained | Buy | $1,334.00(from $1,251.00) |
| Jul 8, 2026 | Truist Securities | Maintained | Buy | $1,370.00(from $1,281.00) |
| Jul 8, 2026 | Morgan Stanley | Maintained | Overweight | $1,347.00(from $1,344.00) |
| Jul 8, 2026 | RBC Capital | Maintained | Outperform | $1,500.00(from $1,250.00) |
| Jul 7, 2026 | JP Morgan | Maintained | Overweight | $1,400.00(from $1,300.00) |
| Jul 6, 2026 | Cantor Fitzgerald | Maintained | Overweight | $1,350.00(from $1,230.00) |
| Jun 25, 2026 | Leerink Partners | Maintained | Outperform | $1,232.00(from $1,119.00) |
| Jun 9, 2026 | Jefferies | Maintained | Buy | $1,350.00(from $1,330.00) |
| May 26, 2026 | B of A Securities | Maintained | Buy | $1,251.00(from $1,133.00) |
| May 5, 2026 | Barclays | Maintained | Overweight | $1,400.00(from $1,350.00) |
| May 5, 2026 | Guggenheim | Reiterated | Buy | $1,183.00 |
| May 4, 2026 | Wolfe Research | Reiterated | Outperform | $1,325.00 |
Source: Yahoo Finance - retrieved just now
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Common questions
What is a price target?
A price target is the share price an analyst expects a stock to reach, usually within twelve months. It follows from that analyst’s own forecasts for the company and their view of what those earnings are worth, so two analysts can publish very different targets on the same company without either being unreasonable.
Do analyst ratings predict returns?
Not reliably. Ratings cluster heavily towards buy across the whole market, they are revised after large price moves at least as often as before them, and a consensus is not an independent set of opinions - analysts read each other. They are most useful as a record of what the sell side currently expects, which is context for a price rather than a forecast of one.
What do upgrade, downgrade and maintained mean?
An upgrade means a firm moved a stock to a more positive rating, a downgrade to a more negative one, and maintained or reiterated means the rating is unchanged even though the firm published a note - often with a revised price target. Initiated means the firm has started covering the company.